MyFinsight
Home
Blog
About
Contact
Download
Download image
us-US
$67,438K
(19.13%↑ Y/Y)
europe-Europe
$34,413K
international-International
$4,826K
total revenue
$106,677K
(13.63%↑ Y/Y)
Income (loss) from
operations
$7,280K
(301.33%↑ Y/Y)
Foreign currency losss
$3,849K
(24.97%↑ Y/Y)
Interest income
$3,418K
(-18.15%↓ Y/Y)
Research and development
expense
$61,113K
(8.23%↑ Y/Y)
Selling, general and
administrative expense
$37,850K
(-5.84%↓ Y/Y)
Cost of revenue from
sale of therapies
$434K
(-47.77%↓ Y/Y)
Other income, net
$1,776K
(-67.53%↓ Y/Y)
Net income before
income taxes
$13,272K
(118.15%↑ Y/Y)
Interest expense
$3,051K
(0.86%↑ Y/Y)
Net income
$12,971K
(158.23%↑ Y/Y)
Income tax expense
$301K
(-71.63%↓ Y/Y)
Total comprehensive
income
$5,682K
(-0.25%↓ Y/Y)
Exchange differences on
translation of foreign...
-$7,289K
(-1183.06%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Immunocore Holdings plc (IMCR)
Immunocore Holdings plc (IMCR)